← Leaderboards
Scott Matthew Knowles
University Of California Los Angeles
$158,204
Attributed
$158,204
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.6K · FY2012–15$50K$37.5K$25K$12.5K$0
'12
'13
'14
'15
Funding mix
By agency
NIH$158,204 · 1
By mechanism
F30$158,204 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Robert E Reiter$11,316,970
- Guido Erwin Michael Eibl$7,914,971
- Hong Wu$8,515,329
- Tanya I Stoyanova$7,579,166
- Ronald T Mitsuyasu$121,811,876
Others in their field
Top investigators on “Adenocarcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$39,462,948
- Anirban Maitra · Johns Hopkins University$30,605,004
- Richard M Peek · Vanderbilt University Medical Center$23,246,493
- Gloria M. Petersen · Johns Hopkins University$21,134,227
- Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr$19,098,764
- Dean E. Brenner · University Of Michigan At Ann Arbor$18,393,816
Research focus
AdenocarcinomaImaging TechniquesAntigensAndrogensAntibodiesBoneBone ImagingCancer ImagingBladderCell SurfaceBloodDensityDepositionDeprivationDiagnosisDisease ProgressionDisseminated Malignant NeoplasmEvaluationHomologous GeneHourHuman Frap1 ProteinImageCharacteristicsImmunodeficient Mouse
Grant awards (4)
AntiPSCA A11 minibody for diagnosis and therapy of prostate cancer$45,555
F30 · FY2015 · CA · contact PI
AntiPSCA A11 minibody for diagnosis and therapy of prostate cancer$45,111
F30 · FY2014 · CA · contact PI
AntiPSCA A11 minibody for diagnosis and therapy of prostate cancer$33,769
F30 · FY2013 · CA · contact PI
AntiPSCA A11 minibody for diagnosis and therapy of prostate cancer$33,769
F30 · FY2012 · CA · contact PI